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West Nile virus (WNV) reemerged in Morocco in
September 2003, causing an equine outbreak. A WNV
strain isolated from a brain biopsy was completely
sequenced. On the basis of phylogenetic analyses,
Moroccan WNV strains isolated during the 1996 and 2003
outbreaks were closely related to other strains responsible
for equine outbreaks in the western Mediterranean basin.
I
n the early 1950s, scientists first recognized that West
Nile virus (WNV) reached outbreak levels in humans in
Egypt and Israel (1,2). Initially considered a minor
arbovirus, WNV has recently emerged as a major public
health and veterinary concern in southern Europe, the
Mediterranean basin, and the United States and Canada
(1–3). Several outbreaks of severe human meningoen-
cephalitis with fatalities have been reported within the last
8 years in Europe and North Africa, specifically in
Romania (1996), Russia (1999), Israel (2000), and Tunisia
(1997, 2003) (1,3). Epizootics in horses have also been
documented in Morocco (1996), Italy (1998), France
(2000), and Israel (2000) (1,4). WNV was responsible for
a cluster of human and equine cases in southern France in
2003 (5,6).
On the basis of phylogenetic analyses, WNV strains
isolated since 1996 in southern Europe and the
Mediterranean basin belong to the clade 1a of lineage 1
(7,8). Moreover, these strains belong to 2 distinct geno-
types (8,9). One cluster includes equine strains isolated in
Italy and France, human strains isolated in Russia and
Israel, and mosquito strains isolated in Romania and
Kenya. The other cluster includes most of the strains iso-
lated from birds and horses in Israel from 1997 to 2001
and the North American isolates. Only 5 strains isolated
in the Mediterranean basin have been completely
sequenced.
Since the first WNV outbreak in Morocco in 1996,
which caused 94 equine cases (including 42 deaths) and 1
human case (10), no WNV infections have been reported.
An outbreak of WNV occurred among horses stabled in
the Moroccan province of Kenitra in September and
October 2003. The complete genome sequence of a WNV
strain isolated from a brain biopsy was characterized, as
well as the complete genome sequence of a strain isolated
during the Morocco 1996 WNV outbreak. We studied phy-
logenetic relationships of the 2 Moroccan strains with
other WNV strains isolated in the Mediterranean basin.
The Study
During the fall of 2003, 9 equine WNV cases were
reported to the Moroccan Ministry of Agriculture. All
horses had acute neurologic symptoms, fever, paresis of
the hindquarters, paralysis, or some combination of these
symptoms (Table); 5 horses were euthanized. Clinical
cases occurred from September 12 to October 1, 2003. No
abnormal bird deaths were observed, and no human cases
were reported.
Equine clinical cases were reported from 3 locations
≈20 to 30 km northeast of Kenitra (34°18'N, 06°30'W),
close to the Sebou River delta and the Atlantic Ocean
(Figure 1). Irrigation networks are developed in this farm-
ing area. In addition, a natural bird reserve, Sidi Boughaba,
is located 15 km southeast of Kenitra, along one of the
migratory Europe–sub-Saharan routes, where numerous
migrating and breeding birds are found.
Virus isolation was performed from a brain biopsy in
the BioPharma laboratory in Rabat, Morocco. Brain sus-
pension was injected onto BSR cells. Cytopathic effect
was observed 4 days after infection. WNV was identified
by immunofluorescence assay and confirmed by reverse
transcription–polymerase chain reaction (RT-PCR). The
complete WNV genome was sequenced in the National
Reference Center for Arboviruses in Lyon, France, after a
single passage of the strain (04.05) on Vero E6 cells.
Twenty-five overlapping amplicons were amplified and
sequenced on both strands (AY701413). The complete
sequence of the strain 96-111 isolated during the 1996
Moroccan equine outbreak was also determined
(AY701412).
Pairwise alignments of 96-111 and 04.05 sequences
using ClustalW1.7 software (11) showed a 98.9%
nucleotide identity and a 99.8% amino-acid identity
between the 2 Moroccan isolates. Six amino-acid differ-
ences were observed between the 2 strains: 1 in the E gene
(I732V), 2 in the NS1 gene (V979I and R1079S), 1 in the
NS2a gene (H1262Y), and 2 in the NS3 gene (F1551L and
A1754T).
Multiple alignments of Moroccan WNV sequences and
other WNV sequences available in GenBank database
were generated by ClustalW1.7 software. Phylogenetic
trees were constructed by using nucleotide alignments, the
Jukes Cantor algorithm, and the neighbor-joining method
implemented in molecular evolutionary genetics analysis
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Comparison of the complete genome sequences
showed a high degree of identity between the Moroccan
strains and those of the European/Mediterranean/Kenyan
cluster. Paired identity at the nucleotide level ranged from
98.2% to 98.9% and from 98.6% to 99% for 04.05 and 96-
111 strains, respectively. Paired nucleotide identity with
strains of the Israeli/American cluster ranged from 96.2%
to 96.3% and 96.5% to 96.6%, respectively. The 5 amino-
acid residues characteristic of the European/
Mediterranean/Kenyan genotype were conserved in both
Moroccan strains, i.e., T416 (E protein), S861 (NS1 pro-
tein), I1861 (NS3 protein), V2209 (NS4a protein), and
D2522 (NS4b protein).
On the basis of the complete genome sequences, phylo-
genetic data showed that both Moroccan strains belonged
to the clade 1a of the lineage 1 and clustered with the
strains of the European/Mediterranean/Kenyan cluster
(Figure 2A). On the basis of the envelope sequences,
equine WNV strains isolated in the Mediterranean basin
from 1996 to 2003 belonged to 2 distinct clusters, i.e., the
European/Mediterranean/Kenyan cluster and the
American/Israeli cluster (Figure 2B). The Moroccan
equine strains clustered with the Italian and French equine
strains. They were more distantly related to the 3 equine
strains isolated in Israel in 2000.
Conclusions
WNV has been circulating in the Mediterranean basin
for a long time (1–3); in the western part of the basin, only
a few isolates have been obtained and completely
sequenced. We report here the isolation and complete
genome characterization of 2 WNV strains involved in
equine outbreaks in Morocco in 1996 and more recently in
2003.
During the late summer of 2003, an equine outbreak
was reported in Morocco. By contrast with the 1996 out-
break (10), the epidemic was restricted geographically and
temporally. Climatic and vectorial conditions might have
been insufficient to lead to a major transmission of the
virus. No young horses were clinically affected, probably
because of the structure of the equine population in Kenitra
Province, where most horses are bought at the age of 4 or
5 years and the mean age of the equine population is 10
years.
High pairwise nucleotide and amino-acid identity val-
ues indicated that the Morocco 1996 and 2003 WNV
strains are closely related. Determining if both outbreaks
were related to an endemic strain or to distinct introduction
events by migratory birds was not possible. Since 1996,
WNV-positive serologic results have been found every
year in horses with neurologic signs, which suggests
endemic circulation of the virus (M. el Harrak, unpub.
data.).
On the basis of envelope and complete genome
sequences, we demonstrated that both Moroccan strains
belonged to the European/Mediterranean/Kenyan cluster
previously defined (8). The characterization of 2 new com-
plete WNV genome sequences allowed us to demonstrate
the genetic stability of the WNV strains involved in the
equine outbreaks reported since 1996 in the western part of
the Mediterranean basin. Our data also suggested the
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Figure 1. Map showing Kenitra Province, where equine clinical
cases occurred in 2003. (adapted from the Internet site http:www.
morocco.com/travel/map03.html)existence of 2 subclusters of WNV strains in the
European/Mediterranean/Kenyan cluster. One subcluster
includes strains isolated in the western Mediterranean
basin (France, Italy, Morocco) that have probably been
introduced from West Africa. The other subcluster includes
strains isolated in the eastern Mediterranean basin (Israel)
and southeastern Europe (Romania, Volgograd) that have
probably been introduced from East Africa. The molecular
epidemiologic features of the strains in the Mediterranean
basin appear to be more complex. Since 1997, at least 2
lineages cocirculate in Israel, i.e., the European/
Mediterranean/Kenyan lineage and the more recent
Israeli/American lineage in birds, equines, and humans
(9,13). Strains of the latter genotype were imported in
1999, probably through infected birds or mosquitos, from
the Middle East to North America, causing high rates of
avian deaths and high rates of illness and deaths in humans
and equines. In Israel, the emergence of the
Israeli/American genotype has also been associated with
avian deaths. Whether the introduction of this genotype is
associated with the high rates of illness and death during
the 2000 human outbreak is unclear. Five amino-acid
residues are known to distinguish the European/
Mediterranean/Kenyan and the Israeli/American geno-
types (7,8). In the future, testing the role of those specific
residues and comparing the biologic properties of strains
of both genotypes will be useful, knowing that only
Israeli/American strains are responsible for avian deaths
(14) and probable increased neurovirulence (15). No virus-
es of the Israeli/American genotype have been isolated
elsewhere in the Mediterranean basin or in Europe.
During the Morocco 2003 outbreak, WNV reemerged
in southern France, causing 7 human and 4 equine cases,
and in Tunisia, causing approximately 200 human cases in
Monastir province (H. Trikki, pers. comm.). No virus iso-
lation or genome amplification was obtained or reported.
Knowing the possibility of transmission through blood
donations, surveillance of WNV infections must be
enhanced in the Mediterranean basin. For the moment, in
contrast with the situation in North America, human and
equine outbreaks have been restricted geographically and
temporally (3). The mechanisms of WNV reintroduction in
Europe and in the Mediterranean basin and the cycle of
maintenance in infected areas remain to be elucidated.
Further studies should focus on competence of mosquito
vectors, identifying bird species involved in the cycle of
transmission, and the persistence mechanisms of the virus
in WNV-endemic areas.
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Figure 2. Phylogenetic trees of West Nile
Virus (WNV) nucleotide sequences.
Phylograms were constructed with the
MEGAprogram, by using the Jukes Cantor
algorithm and the neighbor-joining
method. The percentage of successful
bootstrap replicates is indicated at nodes.
The length of branches is proportional to
the number of nucleotide changes (% of
divergence). The strains sequenced in this
study are indicated by asterisks (*). A)
Complete nucleotide sequence GenBank
accession no. are Italy 1998 (AF404757),
France 2000 (AY268132), Kenya 1998
(AY262283), Romania 1996 (AF260969),
Volgograd 1999 (VLG4) (AF317203),
Volgograd 1999 (27889) (AY277252),
Volgograd 2000 (AY278442), Tunisia 1997
(AY268133), Israel 1998 (AF481864), NY
1999 H (AF202541), NY 1999 EQ
(AF260967), Egypt 1951 (AF260968),
Kunjin 1960 (D00246), Uganda 1937
(M12294). B) Envelope nucleotide
sequence Genbank accession no. are Italy
1998 (AF404757), France 2000
(AY268132), Israël 2000 H (AF394217),
Kenya 1998 (AY262283), Romania 1996
(AF260969), Volgograd 1999 (VLG4)
(AF317203), Volgograd 1999 (27889)
(AY277252), Volgograd 2000 (AY278442),
Tunisia 1997 (AY268133), Israel 1998
(AF481864), Mexico 2003 (AY426741)Acknowledgments
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